10:33 AM EDT, 08/08/2024 (MT Newswires) -- Autolus Therapeutics ( AUTL ) shares were down 4% in recent trading Thursday after the company reported a Q2 net loss of $0.22 per diluted share, narrowing from a loss of $0.26 a year earlier.

Analysts polled by Capital IQ expected a per-share loss of $0.20.

As expected, no revenue for the quarter ended June 30 was reported.

As of June 30, the company said it had $705.9 million in cash and cash equivalents.

Price: 3.86, Change: -0.16, Percent Change: -3.98